Target Group Inc. CBDY OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score

33/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Target Group Inc. (CBDY) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 31/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

33/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

25/100

→ Income

✗

HEALTH

33/100

Debt-to-Equity & liquidity

→ Health

MOAT

50/100

→ Income

GROWTH

48/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — CBDY

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio0.32

EV/EBITDA0.0

Per Share Data

EPS (TTM)$0.00

Book Value / Share$0.00

Revenue / Share$0.01

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2016	$-85.83	$5.92K	$-2.35M	-39624.9%
2017	$-0.72	$15.43K	$-1.74M	-11293.2%
2018	$-0.04	$263.00	$-1.9M	-722433.5%
2019	$-0.03	$0.00	$-10.37M	-
2020	$-0.01	$30K	$-7.07M	-23580%
2021	$0.00	$0.00	$-471K	-
2022	$-0.01	$0.00	$-4.52M	-
2023	$0.00	$3.72M	$-324K	-8.7%
2024	$0.00	$6.59M	$160.5K	2.4%
2025	$0.00	$3.88M	$-1.36M	-35%